Europlasma S.A. (ALEUP.PA)

Europlasma S.A. (ALEUP.PA) — VMCI valuation read

Europlasma S.A. (ALEUP.PA) carries a VMCI composite of 38/100, 12 points below the Industrials sector median of 50. Among mid-cap names, that gap places ALEUP.PA in the bottom third on the five-pillar weighting (Value 35%, Quality 30%, Integrity 15%, Growth 12%, Risk 8%).

The ALEUP.PA insider tape has been silent for the past 30 days on Form 4. Where executives neither buy nor sell, the bull and bear cases lean harder on filings cadence and the next earnings line.

**Investor frame.** Value reads ALEUP.PA trades at 18.0x earnings, 0% above the Industrials median of 18.0x, which compresses or extends through the 11.0x EV/EBITDA versus a Industrials 12.0x. Quality: ROIC of 14.0% sits 4.0pp above the Industrials median (10.0%). Risk: net debt to EBITDA of -1.1x leaves covenant headroom, the line to track on Europlasma S.A.'s next 10-Q.

ALEUP.PA rose 2.3% over the trailing 7 days, with a -14.5% read on a 30-day basis.